Caris & Company Starts Allscripts-Misys (MDRX) at Above Average
Caris & Company initiates coverage on Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX) with an Above Average rating and $19 price target.
For more analyst ratings on MDRX click here.
Allscripts-Misys Healthcare Solutions, Inc. offers software, services, information, and connectivity solutions that enable physicians and other healthcare providers to deliver patient safety and clinical outcomes primarily in the United States.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
